NEW THIO DERIVATIVES BEARING LACTAMS AS POTENT HDAC INHIBITORS AND THEIR USES AS MEDICAMENTS
申请人:SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.
公开号:US20140200205A1
公开(公告)日:2014-07-17
The present invention relates to novel amide compounds of Formula (I), and their use as anti-tumoral and pro-apoptotic agents. The invention includes the use of such compounds in medicine, in relation to cancer disease as well as other diseases where an inhibition of HDAC is responsive, and the pharmaceutical composition containing such compounds.
本发明涉及式(I)的新型酰胺化合物,以及它们作为抗肿瘤和促凋亡剂的用途。该发明涉及这些化合物在医学上的应用,与癌症以及其他需要抑制HDAC的疾病有关,以及含有这些化合物的药物组合物。